These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 19887247)
21. The DNA methylome of glioblastoma multiforme. Martinez R; Esteller M Neurobiol Dis; 2010 Jul; 39(1):40-6. PubMed ID: 20064612 [TBL] [Abstract][Full Text] [Related]
22. CpG island promoter hypermethylation of the pro-apoptotic gene caspase-8 is a common hallmark of relapsed glioblastoma multiforme. Martinez R; Setien F; Voelter C; Casado S; Quesada MP; Schackert G; Esteller M Carcinogenesis; 2007 Jun; 28(6):1264-8. PubMed ID: 17272309 [TBL] [Abstract][Full Text] [Related]
23. A silver lining on the horizon for glioblastoma. Knisely JP; Baehring JM Lancet Oncol; 2009 May; 10(5):434-5. PubMed ID: 19410186 [No Abstract] [Full Text] [Related]
24. Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas. Lavon I; Zrihan D; Zelikovitch B; Fellig Y; Fuchs D; Soffer D; Siegal T Clin Cancer Res; 2007 Mar; 13(5):1429-37. PubMed ID: 17332285 [TBL] [Abstract][Full Text] [Related]
25. Gene regulation by methylation. Mueller WC; von Deimling A Recent Results Cancer Res; 2009; 171():217-39. PubMed ID: 19322547 [TBL] [Abstract][Full Text] [Related]
26. Epigenetic alterations in glioblastomas: Diagnostic, prognostic and therapeutic relevance. Montella L; Cuomo M; Del Gaudio N; Buonaiuto M; Costabile D; Visconti R; Di Risi T; Vinciguerra R; Trio F; Ferraro S; Bove G; Facchini G; Altucci L; Chiariotti L; Della Monica R Int J Cancer; 2023 Aug; 153(3):476-488. PubMed ID: 36479695 [TBL] [Abstract][Full Text] [Related]
27. Socioeconomic Disparities Associated With MGMT Promoter Methylation Testing for Patients With Glioblastoma. Lamba N; Chukwueke UN; Smith TR; Ligon KL; Aizer A; Reardon DA; Iorgulescu JB JAMA Oncol; 2020 Dec; 6(12):1972-1974. PubMed ID: 33090181 [TBL] [Abstract][Full Text] [Related]
28. Differential gene methylation in paired glioblastomas suggests a role of immune response pathways in tumor progression. Alentorn A; Durán-Peña A; Malousi A; Marie Y; Mokhtari K; Sanson M; Hoang-Xuan K; Delattre JY; Idbaih A; Vecht C J Neurooncol; 2015 Sep; 124(3):385-92. PubMed ID: 26224161 [TBL] [Abstract][Full Text] [Related]
29. MGMT methylation in diffuse large B-cell lymphoma: validation of quantitative methylation-specific PCR and comparison with MGMT protein expression. Uccella S; Cerutti R; Placidi C; Marchet S; Carnevali I; Bernasconi B; Proserpio I; Pinotti G; Tibiletti MG; Furlan D; Capella C J Clin Pathol; 2009 Aug; 62(8):715-23. PubMed ID: 19638543 [TBL] [Abstract][Full Text] [Related]
30. Role of epigenetic changes in hematological malignancies. Lehmann U; Brakensiek K; Kreipe H Ann Hematol; 2004 Mar; 83(3):137-52. PubMed ID: 15064862 [TBL] [Abstract][Full Text] [Related]
31. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
32. [Genetic and molecular abnormalities of glioblastomas (GBM)]. Larsen C Bull Cancer; 2010 Nov; 97(11):1389-407. PubMed ID: 21084244 [TBL] [Abstract][Full Text] [Related]
33. The HDAC Inhibitors Scriptaid and LBH589 Combined with the Oncolytic Virus Delta24-RGD Exert Enhanced Anti-Tumor Efficacy in Patient-Derived Glioblastoma Cells. Berghauser Pont LM; Kleijn A; Kloezeman JJ; van den Bossche W; Kaufmann JK; de Vrij J; Leenstra S; Dirven CM; Lamfers ML PLoS One; 2015; 10(5):e0127058. PubMed ID: 25993039 [TBL] [Abstract][Full Text] [Related]
34. Diversity of cytogenetic and pathohistologic profiles in glioblastoma. Hassler M; Seidl S; Fazeny-Doerner B; Preusser M; Hainfellner J; Rössler K; Prayer D; Marosi C Cancer Genet Cytogenet; 2006 Apr; 166(1):46-55. PubMed ID: 16616111 [TBL] [Abstract][Full Text] [Related]
36. Favoritism in DNA methylation. Hitchins MP; Ward RL Cancer Prev Res (Phila); 2009 Oct; 2(10):847-9. PubMed ID: 19789293 [TBL] [Abstract][Full Text] [Related]
37. Careful exclusion of non-neoplastic brain components is required for an appropriate evaluation of O6-methylguanine-DNA methyltransferase status in glioma: relationship between immunohistochemistry and methylation analysis. Sasai K; Nodagashira M; Nishihara H; Aoyanagi E; Wang L; Katoh M; Murata J; Ozaki Y; Ito T; Fujimoto S; Kaneko S; Nagashima K; Tanaka S Am J Surg Pathol; 2008 Aug; 32(8):1220-7. PubMed ID: 18580490 [TBL] [Abstract][Full Text] [Related]
38. Chemoprotection in glioblastoma therapy: reality or a dream? Mrugala MM; Adair J; Kiem HP CNS Oncol; 2012 Sep; 1(1):11-4. PubMed ID: 25054293 [No Abstract] [Full Text] [Related]
39. Oligonucleotide DNA chips are useful adjuncts in epigenetic studies of glioblastomas. Kim B; Kim H; Song BJ; Cha SH; Lee MO; Park SH Neuropathology; 2006 Oct; 26(5):409-16. PubMed ID: 17080717 [TBL] [Abstract][Full Text] [Related]
40. Molecular profiling in glioblastoma: prelude to personalized treatment. Mladkova N; Chakravarti A Curr Oncol Rep; 2009 Jan; 11(1):53-61. PubMed ID: 19080742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]